BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6182600)

  • 1. [Inhibited depressions, clinical and spinal fluid findings].
    Roccatagliata G; Albano C; Bartolini A
    Riv Neurol; 1982; 52(4):212-7. PubMed ID: 6182600
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebrospinal HVA and 5-HIAA in patients with endogenous depression in the course of treatment].
    Loeb DC; Roccatagliata G; Albano C; Abbruzzese G
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):27-32. PubMed ID: 6158092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic effect of Trazodon with endogenous depressions.
    Peterova E; Vencovsky E
    Agressologie; 1981 Nov; 22(E):25. PubMed ID: 7332045
    [No Abstract]   [Full Text] [Related]  

  • 4. CSF monoamine metabolites during treatment with mianserin or amitryptyline.
    Mendlewicz J; Pinder RM; Stulemeijer SM; van Dorth R
    Adv Biochem Psychopharmacol; 1982; 32():249-56. PubMed ID: 6178263
    [No Abstract]   [Full Text] [Related]  

  • 5. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid of patients with acute cerebrovascular lesion.
    Livrea P; Papagno G; Di Reda L; Centrone G
    Acta Neurol (Napoli); 1976; 31(5):647-51. PubMed ID: 1015387
    [No Abstract]   [Full Text] [Related]  

  • 6. Higher CSF levels of HVA and 5-HIAA in delusional compared to nondelusional depression.
    Aberg-Wistedt A; Wistedt B; Bertilsson L
    Arch Gen Psychiatry; 1985 Sep; 42(9):925-6. PubMed ID: 2412522
    [No Abstract]   [Full Text] [Related]  

  • 7. Parallel variation of homovanillic acid and 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid of man.
    Inagawa T; Mori S; Yoshimoto H; Ishikawa S; Uozumi T
    Hiroshima J Med Sci; 1976 Sep; 25(2-3):79-87. PubMed ID: 1026667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic effects of trazodone in endogenous depressions (author's transl)].
    Vencovský E; Peterová E
    Cesk Psychiatr; 1982 Apr; 78(2):123-6. PubMed ID: 7083363
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of two new antidepressants.
    Gershon S; Georgotas A; Newton R; Bush D
    Adv Biochem Psychopharmacol; 1982; 32():57-68. PubMed ID: 6211943
    [No Abstract]   [Full Text] [Related]  

  • 10. Parallel variation of homovanillic acid, 5-hydroxyindoleacetic acid and cyclic adenosine-3, 5-monophosphate in ventricular cerebrospinal fluid of man.
    Inagawa T
    Hiroshima J Med Sci; 1982 Jun; 31(2):117-21. PubMed ID: 6182129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Late chronic dyskinesia from neuroleptic drugs (CSF and pharmacological data) (author's transl)].
    Roccatagliata G; Albano C; Besio G
    Riv Patol Nerv Ment; 1978 Sep; 98(4):228-32. PubMed ID: 33440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trazodone in the treatment of neurotic depression.
    Goldberg HL; Finnerty RJ
    J Clin Psychiatry; 1980 Dec; 41(12 Pt 1):430-4. PubMed ID: 7440519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Bottiglieri T; Lim CK; Peters TJ
    J Chromatogr; 1984 Nov; 311(2):354-60. PubMed ID: 6084013
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction.
    Stelmasiak Z
    Neuropatol Pol; 1982; 20(1-2):97-105. PubMed ID: 6191248
    [No Abstract]   [Full Text] [Related]  

  • 16. Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices.
    Agren H; Terenius L
    J Affect Disord; 1985 Jul; 9(1):25-34. PubMed ID: 2410472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPT axis, CSF monoamine metabolites, suicide intent and depression severity in male suicide attempters.
    Jokinen J; Samuelsson M; Nordström AL; Nordström P
    J Affect Disord; 2008 Nov; 111(1):119-24. PubMed ID: 18342374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid amine metabolic end-products: biochemical correlates of intelligence.
    Sishta SK; Templer DI
    Res Commun Chem Pathol Pharmacol; 1975 Nov; 12(3):601-4. PubMed ID: 128085
    [No Abstract]   [Full Text] [Related]  

  • 19. Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders.
    Kasa K; Otsuki S; Yamamoto M; Sato M; Kuroda H; Ogawa N
    Biol Psychiatry; 1982 Aug; 17(8):877-83. PubMed ID: 7115838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic metabolites of dopamine and serotonin in cerebrospinal fluid.
    Sourkes TL
    Adv Neurol; 1974; 5():271-3. PubMed ID: 4440576
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.